WT1 and neoplasm: Out of 14 tumor samples from the 9 patients with germline WT1 variants, 10 (71.4%) were found to have acquired tumor somatic activating variants in exon 3 of CTNNB1, which codes for the Wnt pathway effector transcription factor β-Catenin.